APA (7th ed.) Citation

Parker, J. M., Glaspole, I. N., Lancaster, L. H., Haddad, T. J., She, D., Roseti, S. L., . . . Flaherty, K. R. (2018). A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine, 197(1), 94-103. https://doi.org/10.1164/rccm.201704-0784OC

Chicago Style (17th ed.) Citation

Parker, Joseph M., et al. "A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis." American Journal of Respiratory and Critical Care Medicine 197, no. 1 (2018): 94-103. https://doi.org/10.1164/rccm.201704-0784OC.

MLA (9th ed.) Citation

Parker, Joseph M., et al. "A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary Fibrosis." American Journal of Respiratory and Critical Care Medicine, vol. 197, no. 1, 2018, pp. 94-103, https://doi.org/10.1164/rccm.201704-0784OC.